ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.188,34
-1,00%
S&P 500
5.214,08
0,51%
US Dollar vs BRL
5,1423
1,04%
Bitcoin
62.933,89
-0,18%
Brent Oil
83,995
0,05%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. BridgeBio Pharma Inc (BBIO)

  7. BridgeBio Pharma Inc (BBIO) Notícias

BBIO BridgeBio Pharma Inc

28,10
0,40 (1,44%)
Após o horário de negociação
Última atualização: 19:43:41
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
BridgeBio Pharma Inc BBIO NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,40 1,44% 28,10 19:43:41
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
27,67 27,38 28,755 28,73 27,70
mais cotações »

Notícias Recentes

Data Hora Fonte Título
02/05/202408:30GLOBEBridgeBio Pharma Reports First Quarter 2024 Financial..
02/05/202408:00GLOBEBridgeBio launches BridgeBio Oncology Therapeutics (BBOT)..
10/04/202408:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
07/04/202414:15GLOBEBridgeBio Pharma Presents Cardiac Magnetic Resonance (CMR)..
20/03/202408:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
06/03/202401:53GLOBEBridgeBio Pharma Announces Pricing of Public Offering of..
04/03/202418:17GLOBEBridgeBio Pharma Announces Proposed Public Offering of..
04/03/202404:30GLOBEBridgeBio Pharma and Bayer Announce European Licensing..
22/02/202409:30GLOBEBridgeBio Pharma Reports Fourth Quarter and Full Year 2023..
07/02/202409:34GLOBEBridgeBio Pharma and Kyowa Kirin Announce Partnership with..
06/02/202409:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
05/02/202409:30GLOBEBridgeBio Pharma Announces U.S. Food and Drug Administration..
02/02/202409:00GLOBEBridgeBio Pharma Shares Positive Results of Single-Arm Phase..
30/01/202409:00PRNUSInvitae Partners with BridgeBio Pharma to Harness Genetic..
18/01/202409:00GLOBEBridgeBio Pharma Secures up to $1.25 Billion of Capital from..
10/01/202419:15GLOBEBridgeBio Pharma Announces Publication of Positive Results..
10/01/202409:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
03/01/202418:30GLOBEBridgeBio Pharma to Participate in the J.P. Morgan..
03/01/202409:30GLOBEBridgeBio announces FDA clearance of IND application for..
13/12/202309:30GLOBEBridgeBio Announces First Child Dosed in PROPEL 3, its Phase..
08/12/202309:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
05/12/202310:52DJNBridgeBio Seeks FDA Approval of Acoramidis in Transthyretin..
05/12/202309:44GLOBEBridgeBio Pharma Announces Submission of New Drug..
12/11/202312:30GLOBEBridgeBio Pharma Presents Additional Clinical Outcomes Data..
09/11/202309:30GLOBEBridgeBio Pharma to Present Additional Data from the Phase 3..
08/11/202309:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
02/11/202308:30GLOBEBridgeBio Pharma Reports Third Quarter 2023 Financial..
11/10/202308:30GLOBEBridgeBio Pharma Reports Inducement Grants Under Nasdaq..
10/10/202308:30GLOBEBridgeBio Pharma Announces New England Journal of Medicine..
09/10/202308:30GLOBEBridgeBio Pharma Shares Positive Long-Term Data from an..
03/10/202308:31BWBridgeBio and Resilience Announce Strategic Multi-Year..
03/10/202308:30GLOBEBridgeBio and Resilience Announce Strategic Multi-Year..
25/09/202308:30GLOBEBridgeBio Pharma Announces $250 Million Private Placement..
08/09/202308:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
07/09/202308:30GLOBEBridgeBio Pharma to Participate in the Morgan Stanley 21st..
06/09/202308:30GLOBEBridgeBio Pharma Announces Positive Feedback from the U.S...
27/08/202307:15GLOBEBridgeBio presents detailed positive results from Phase 3..
24/08/202317:01GLOBEBridgeBio Pharma to Present Detailed Results from the Phase..
04/08/202308:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
03/08/202308:30GLOBEBridgeBio Pharma Reports Second Quarter 2023 Financial..
31/07/202308:30GLOBEBridgeBio Pharma Announces Opportunity for Accelerated..
18/07/202308:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
18/07/202308:27IHMARKETNEWSTuesday’s Wall Street Highlights: Novartis, BofA, Dollar..
17/07/202308:00GLOBEBridgeBio announces consistently positive results from Phase..
14/07/202317:01GLOBEBridgeBio to Host Investor Call to Share Topline 30-month..
12/07/202317:31GLOBEBurjeel Holdings to Launch Rare Disease Research &..
20/06/202308:30GLOBEBridgeBio Pharma Presents Updated Six Month Results from its..
13/06/202308:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
08/06/202308:30GLOBEBridgeBio Pharma to Present Updated Six Month Results from..
22/05/202308:30GLOBEBridgeBio Pharma Presents Updated Encouraging Clinical and..

Seu Histórico Recente

NASDAQ
BBIO
BridgeBio Pharma
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados